Paladin Labs Acquires Allon Therapeutics
Vancouver-based Allon Therapeutics Inc. (TSX: NPC), which is focused on bringing to market central nervous system therapies, has been acquired for an undisclosed sum by Paladin Labs Inc. (TSX:PLB), a specialty pharmaceuticals company based in Montréal. Allon Therapeutics earlier this year filed a proposal for bankruptcy and reorganization. The company was backed by Canadian venture capital firm NDI Capital and other investors.
18 July 2013•3 mins read
